Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sofinnova Investments
Menlo Park, California, United Statessofinnova.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Sofinnova Investments does not conduct its own clinical trials but invests in biopharma/biotech companies at all stages of development. Its portfolio includes multiple successful exits via acquisition or IPOs for drugs addressing high unmet needs in rare disease, oncology, ophthalmology and more. Recent investments include gene therapies for blindness and innovative biologics for rare conditions. The firm has backed several first-in-class or best-in-class therapeutics that have reached late-stage clinical development or approval through its portfolio companies.
- Therapeutic areas
- OphthalmologyImmunologyEndocrinologyOncologyRare DiseasesInfectious Diseases
- Modalities
- Gene therapySmall moleculeMonoclonal antibodyBiologic
- Industry
- Investors
02
Partnerships
As an investor/VC they partner with biotech/pharma startups rather than forming traditional pharma partnerships themselves.
Beyond the preview
Go deeper on Sofinnova Investments.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sofinnova Investments.